(RTTNews) - National Resilience, Inc. and Moderna, Inc. (MRNA) announced a multi-year agreement, under which Resilience will produce mRNA for the Moderna COVID-19 vaccine at its facility in Mississauga, Ontario in Canada, for distribution worldwide.
Resilience is a manufacturing and technology company which aims to free partners to focus on the discoveries that improve patients' lives. The company is building a sustainable network of high-tech, end-to-end manufacturing solutions with the aim to ensure the medicines can be made quickly, safely, and at scale.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
